Investment
Features
FeesSafety
Academy
More
Pluang+

UnitedHealth beats Q2 earnings, raises 2026 guidance, remains a buy despite recent underperformance.

Company Fundamentals
15 Sep 2026
Seeking Alpha
View Source
Bullish
UnitedHealth beats Q2 earnings, raises 2026 guidance, remains a buy despite recent underperformance.

UnitedHealth Group reported strong Q2 results with beats on revenue and EPS, and raised its full-year 2026 guidance. The company maintained a stable medical loss ratio of 86.7%, and analysts have upgraded EPS estimates with no downgrades, reflecting confidence in its long-term growth. Despite recent underperformance against the S&P 500, UnitedHealth's valuation remains attractive with a 6.9% free cash flow yield. Technically, the stock shows a bullish primary trend but faces key support levels around mid-$350s, with potential downside if it drops below $370.

Following UnitedHealth's upbeat 2026 outlook, its stock price on Pluang stands at USD 382.00 as of Sep 15, 2026 16:41 WIB, showing a slight 0.40% decline over the day. The company holds a market capitalization of $340.27 billion and offers a dividend yield of 2.45%, reflecting its strong position in the health sector despite recent price fluctuations.

More News (UNH)

UnitedHealth Group shows strong profit growth despite flat revenue, stock undervalued ahead of Q3 results.

UnitedHealth Group shows strong profit growth despite flat revenue, stock undervalued ahead of Q3 results.

UnitedHealth Group is rated a conditional Buy as its profitability improves significantly despite flat revenue and shrinking membership. The company has exited unprofitable business lines, driving margin expansion. Its current valuation is below the ...

Company Fundamentals
Bullish
1 day ago
Humana shares jump 16% on improved Medicare Advantage Star Ratings; CVS falls 3%, UnitedHealth steady.

Humana shares jump 16% on improved Medicare Advantage Star Ratings; CVS falls 3%, UnitedHealth steady.

Humana's stock surged 16% after the company announced improved Medicare Advantage Star Ratings for 2027, with 95% of its members enrolled in plans rated four stars or higher. This improvement reflects better preventive care and earlier disease detect...

Market News
Bullish
1 day ago
Law firm probes UnitedHealth officers for possible breach of duties to shareholders

Law firm probes UnitedHealth officers for possible breach of duties to shareholders

Halper Sadeh LLC is investigating whether certain UnitedHealth Group officers and directors violated their fiduciary duties to shareholders. Long-term shareholders of UnitedHealth stock may be eligible to seek corporate governance reforms, financial ...

Market News
Bearish
2 days ago
UnitedHealth Group Q3 earnings preview: $4.12 EPS expected, focus on Medicare Advantage trends and medical costs.

UnitedHealth Group Q3 earnings preview: $4.12 EPS expected, focus on Medicare Advantage trends and medical costs.

UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...

Company Fundamentals
Neutral
2 days ago
Medicare Advantage plans are shutting down, risking coverage changes for nearly 1M members.

Medicare Advantage plans are shutting down, risking coverage changes for nearly 1M members.

Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...

Market News
Neutral
3 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App